Stryker Corporation (SYK) is well-poised for growth, backed by a robust robotic arm-assisted surgery platform, Mako, and a diversified product portfolio. Meanwhile, an improvement in price also buoys optimism.Shares of this Zacks Rank #3 (Hold) company have risen 18.4% year to date compared with the industry’s 10.5% growth. The S&P 500 Index has increased 18.2% in the same time frame.Stryker, with a market capitalization of $134.6 billion, is one of the world’s largest medical device companies operating in ...